Hey everyone, Nuked here! Today, let’s explore the exciting world of aging and technology.

Imagine a startup making huge waves by developing treatments that could make cells act younger. This company, founded by Coinbase’s CEO Brian Armstrong, has just raised a remarkable $130 million to push the boundaries of lifespan extension.

With innovations in genetic programming and AI, they are discovering prototype medicines that rejuvenate liver cells, restoring their ability to process fat and alcohol. These breakthroughs are based on experiments showing that older cells can behave like their youthful counterparts, a promising leap toward anti-aging therapies.

While they’re still a few years away from testing on humans, their strategy involves using AI models to simulate experiments. This means they only pursue the most promising drug candidates, speeding up discovery and reducing costs.

In the broader context, other biotech startups like Retro Biosciences and Altos Labs are also racing to extend human lifespan, with investments running into hundreds of millions or even billions of dollars. These efforts are fueled by visionary investors and groundbreaking science, making the dream of longer, healthier lives more tangible than ever.

So stay tuned to see how science and AI may someday help us all live more vibrant, youthful lives!